A role for BRCA2 splice variants in BRCA2 wild-type ovarian cancer has been suggested by a recent study investigating the effect of the splicing factor small nuclear ribonucleoprotein B (SNRPB) [52]. The gene discussed is SNRPB; the disease is ovarian carcinoma.